PHK
PBYI icon

Point72 Hong Kong’s Puma Biotechnology PBYI Stock Holding History

Point72 Hong Kong’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-5,315
Closed -$49K – 2331
2021
Q2 		$49K Buy
+5,315
New +$53.9K ﹤0.01% 1475
2019
Q3 		– Sell
-1,604
Closed -$20K – 1257
2019
Q2 		$20K Buy
+1,604
New +$36.9K 0.01% 779
2018
Q3 		– Sell
-37
Closed -$2K – 1110
2018
Q2 		$2K Sell
37
-12
-24% -$695 ﹤0.01% 786
2018
Q1 		$3K Buy
49
+9
+23% +$674 ﹤0.01% 766
2017
Q4 		$4K Buy
+40
New +$4.48K ﹤0.01% 619
2017
Q1 		– Sell
-119
Closed -$4K – 910
2016
Q4 		$4K Buy
+119
New +$5.14K ﹤0.01% 735
2016
Q2 		– Sell
-900
Closed -$26K – 632
2016
Q1 		$26K Buy
+900
New +$40.7K 0.05% 249

Other funds holding PBYI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

Point72 Hong Kong's PBYI Position: Q3 2021 in Review

Point72 Hong Kong sold out of Puma Biotechnology (PBYI) in Q3 2021, closing a stake of 5,315 shares — an estimated $49K sold.

Point72 Hong Kong first reported a position in PBYI in Q1 2016 and held it in 7 quarters. The position peaked at $49K in Q2 2021. 115 funds tracked by Wall St. Rank hold PBYI as of Q3 2021.

  • Point72 Hong Kong reported no remaining Puma Biotechnology position as of Q3 2021 after selling out during the quarter.
  • Point72 Hong Kong sold 5,315 Puma Biotechnology shares in Q3 2021, an estimated $49K.
  • Point72 Hong Kong first reported a position in Puma Biotechnology in Q1 2016 and held it in 7 quarters.
  • Point72 Hong Kong's Puma Biotechnology position peaked at $49K in Q2 2021.
  • 115 funds tracked by Wall St. Rank held Puma Biotechnology as of Q3 2021.

Based on Point72 Hong Kong's 13F filing for Q3 2021, filed 15 Nov 2021.